The reasons for these results include:
• Institutional investors strongly represent the industry
• The ACA’s 2.3 percent medical device excise tax
• Increased mergers and acquisition leading to increased financial leverage
• Main financial ratios look high
• Litigation-related charges and impairments impacted profitability
The top 10 companies are:
1. Boston Scientific
2. Medtronic plc
3. Abbott Laboratories
4. Edwards Lifesciences
5. Becton, Dickson and Company
6. C.R. Bard
7. St. Jude Medical
8 Baxter
9. Stryker
10 Zimmer Biomet
More articles on orthopedic devices:
5 observations on Amedica shares dropping by 15.92%
Global MIS market to grow to $50B+ by 2019: 7 key trends
ExactechGPS launches globally: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
